MO2-16-3Population PK/PD Analysis of Necitumumab: Dose...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

MO2-16-3Population PK/PD Analysis of Necitumumab: Dose justification for Squamous Cell Lung Cancer (SqCLC) Patients in Japan

Mimura, Hanaka, Long, Amanda, Chigutsa, Emmanuel, Wallin, Johan, Enatsu, Sotaro, Nakagawa, Kazuhiko, Tamura, Tomohide
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz338.082
Date:
October, 2019
File:
PDF, 79 KB
2019
Conversion to is in progress
Conversion to is failed